Cargando…

Home oxygen therapy

Long-term home oxygen therapy improves survival in patients with chronic obstructive pulmonary disease and persistent, severe hypoxaemia. It is uncertain that this benefit extends to patients with other chronic lung diseases. Oxygen is a treatment for hypoxaemia, not breathlessness. To confirm hypox...

Descripción completa

Detalles Bibliográficos
Autor principal: McDonald, Christine F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882449/
https://www.ncbi.nlm.nih.gov/pubmed/35233135
http://dx.doi.org/10.18773/austprescr.2022.007
_version_ 1784659702918938624
author McDonald, Christine F
author_facet McDonald, Christine F
author_sort McDonald, Christine F
collection PubMed
description Long-term home oxygen therapy improves survival in patients with chronic obstructive pulmonary disease and persistent, severe hypoxaemia. It is uncertain that this benefit extends to patients with other chronic lung diseases. Oxygen is a treatment for hypoxaemia, not breathlessness. To confirm hypoxaemia, blood gas analysis is recommended before prescribing oxygen. There is limited and conflicting evidence that portable oxygen for exertional use is of benefit to patients with chronic obstructive pulmonary disease who do not have severe hypoxaemia. Laboratory studies show improvements in exercise capacity and dyspnoea, but these do not translate into significant benefits in the home setting. Patients should be educated regarding the expected benefits, risks and burdens of home oxygen therapy. It is particularly important that the patient does not smoke.
format Online
Article
Text
id pubmed-8882449
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-88824492022-02-28 Home oxygen therapy McDonald, Christine F Aust Prescr Article Long-term home oxygen therapy improves survival in patients with chronic obstructive pulmonary disease and persistent, severe hypoxaemia. It is uncertain that this benefit extends to patients with other chronic lung diseases. Oxygen is a treatment for hypoxaemia, not breathlessness. To confirm hypoxaemia, blood gas analysis is recommended before prescribing oxygen. There is limited and conflicting evidence that portable oxygen for exertional use is of benefit to patients with chronic obstructive pulmonary disease who do not have severe hypoxaemia. Laboratory studies show improvements in exercise capacity and dyspnoea, but these do not translate into significant benefits in the home setting. Patients should be educated regarding the expected benefits, risks and burdens of home oxygen therapy. It is particularly important that the patient does not smoke. NPS MedicineWise 2022-02-01 2022-02 /pmc/articles/PMC8882449/ /pubmed/35233135 http://dx.doi.org/10.18773/austprescr.2022.007 Text en (c) NPS MedicineWise https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle Article
McDonald, Christine F
Home oxygen therapy
title Home oxygen therapy
title_full Home oxygen therapy
title_fullStr Home oxygen therapy
title_full_unstemmed Home oxygen therapy
title_short Home oxygen therapy
title_sort home oxygen therapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882449/
https://www.ncbi.nlm.nih.gov/pubmed/35233135
http://dx.doi.org/10.18773/austprescr.2022.007
work_keys_str_mv AT mcdonaldchristinef homeoxygentherapy